Compare ISTR & ABSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ISTR | ABSI |
|---|---|---|
| Founded | 2006 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 405.9M | 418.0M |
| IPO Year | 2014 | 2021 |
| Metric | ISTR | ABSI |
|---|---|---|
| Price | $29.14 | $2.81 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 6 |
| Target Price | ★ $29.00 | $7.98 |
| AVG Volume (30 Days) | 116.2K | ★ 2.8M |
| Earning Date | 04-22-2026 | 01-01-0001 |
| Dividend Yield | ★ 1.51% | N/A |
| EPS Growth | 20.71 | ★ 21.67 |
| EPS | ★ 1.62 | N/A |
| Revenue | N/A | ★ $4,534,000.00 |
| Revenue This Year | $66.03 | $10.72 |
| Revenue Next Year | $5.18 | $313.07 |
| P/E Ratio | $17.94 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $15.39 | $2.01 |
| 52 Week High | $30.49 | $5.23 |
| Indicator | ISTR | ABSI |
|---|---|---|
| Relative Strength Index (RSI) | 53.81 | 48.65 |
| Support Level | $28.79 | $2.49 |
| Resistance Level | $30.49 | $2.89 |
| Average True Range (ATR) | 0.80 | 0.18 |
| MACD | -0.18 | 0.04 |
| Stochastic Oscillator | 38.07 | 94.25 |
Investar Holding Corp is a U.S.-based financial holding company. Through its subsidiaries, it offers a variety of commercial and retail lending products throughout its market areas, including business loans to small to medium-sized businesses, as well as loans to individuals. It has business operations spread across the United States and serves its customers through several service branches. The bank also offers cashiers' checks, direct deposit of payroll and Social Security checks, night depository, bank-by-mail, automated teller machines with deposit automation, and debit cards.
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.